Literature DB >> 9624416

Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.

X P Hao1, T Günther, A Roessner, A B Price, I C Talbot.   

Abstract

AIMS: To evaluate the respective roles of mdm2 (murine double minute 2) and p53 in the development of colorectal carcinoma.
METHODS: Formalin fixed, paraffin wax embedded tissues from 72 sporadic adenomas and 55 carcinomas were investigated by means of immunohistochemistry for mdm2 and p53.
RESULTS: mdm2 was expressed weakly in 17 of 72 (23.6%) adenomas and in 14 of 55 (25.4%) carcinomas. p53 was expressed in 19 of 72 (26.4%) adenomas and in 23 of 55 (41.8%) carcinomas. Four adenomas and five carcinomas showed positive staining for both proteins. Overexpression of p53 in adenomas was associated with moderate and severe dysplasia but not with tumour size. No associations were found between the expression of mdm2 and either the degree of dysplasia or tumour size. In carcinomas, neither the expression of p53 nor mdm2 correlated with Dukes's stage, metastasis, or differentiation. No associations were found between the expression of p53 and mdm2 in either adenomas or carcinomas.
CONCLUSIONS: Although mdm2 has been reported to be an oncogene, it does not appear to play a major role in the development of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624416      PMCID: PMC395604          DOI: 10.1136/mp.51.1.26

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  23 in total

1.  The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.

Authors:  T Watanabe; T Hotta; A Ichikawa; T Kinoshita; H Nagai; T Uchida; T Murate; H Saito
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

2.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

3.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

4.  Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.

Authors:  C Cordon-Cardo; E Latres; M Drobnjak; M R Oliva; D Pollack; J M Woodruff; V Marechal; J Chen; M F Brennan; A J Levine
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

5.  p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.

Authors:  T D Kessis; R J Slebos; S M Han; K Shah; X F Bosch; N Muñoz; L Hedrick; K R Cho
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  MDM2 gene amplification in metastatic osteosarcoma.

Authors:  M Ladanyi; C Cha; R Lewis; S C Jhanwar; A G Huvos; J H Healey
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

7.  bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

Authors:  F A Sinicrope; S B Ruan; K R Cleary; L C Stephens; J J Lee; B Levin
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

8.  Interaction between the retinoblastoma protein and the oncoprotein MDM2.

Authors:  Z X Xiao; J Chen; A J Levine; N Modjtahedi; J Xing; W R Sellers; D M Livingston
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

9.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

Authors:  G Reifenberger; L Liu; K Ichimura; E E Schmidt; V P Collins
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

View more
  7 in total

1.  MDM2/p53 protein expression in the development of colorectal adenocarcinoma.

Authors:  G Abdel-Fattah; B Yoffe; B Krishnan; V Khaoustov; K Itani
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

2.  Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.

Authors:  Yu-Chao Lin; Wen-Shin Chang; Te-Chun Shen; Hsin-Ting Li; Chia-Hsiang Li; Yu-Chen Hsiau; Yun-Chi Wang; Cheng-Nan Wu; Chi-Li Gong; Zhi-Hong Wang; Chia-Wen Tsai; Te-Chun Hsia; DA-Tian Bau
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.

Authors:  Qiang Fu; Guoqiang Zhang; Hongwei Chen; Youwei Zheng; Jing Cheng
Journal:  Tumour Biol       Date:  2013-08-03

4.  Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.

Authors:  Te-Cheng Yueh; Yi-Wen Hung; Tzu-Ching Shih; Cheng-Nan Wu; Shou-Cheng Wang; Yi-Liang Lai; Shih-Wei Hsu; Ming-Hsien Wu; Chun-Kai Fu; Yun-Chi Wang; Tao-Wei Ke; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

5.  MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?

Authors:  Monirath Hav; Louis Libbrecht; Liesbeth Ferdinande; Piet Pattyn; Stephanie Laurent; Marc Peeters; Marleen Praet; Patrick Pauwels
Journal:  Virchows Arch       Date:  2010-11-27       Impact factor: 4.064

6.  Potential role of apoptosis and apoptotic regulatory proteins in colorectal neoplasia: correlations with clinico-pathological parameters and survival.

Authors:  Maria Tzouvala; Andreas C Lazaris; George V Papatheodoridis; Chariklia Kouvidou; Thomas G Papathomas; Nikos Kavantzas; Ioannis Elemenoglou; Demetrios G Karamanolis; Emmanouil Agapitos
Journal:  Dig Dis Sci       Date:  2007-06-12       Impact factor: 3.199

7.  MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.

Authors:  X J Li; M Murai; T Koyama; D Y Wang; K Hashimoto
Journal:  Jpn J Cancer Res       Date:  2000-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.